| Gene/Event | Cancer Type | Patient | Variant | Mutation Level |
|---|---|---|---|---|
| IVL | Breast Cancer | p111_p3-92 | p.L215V | Branch mutation |
| IVL | Breast Cancer | p111_p3-92 | p.Q218E | Branch mutation |
| IVL | Breast Cancer | p111_p3-92 | p.E220K | Branch mutation |
| IVL | Breast Cancer | p111_p3-92 | p.E220V | Branch mutation |
| IVL | Breast Cancer | p111_p3-92 | p.P226S | Branch mutation |
| IVL | Breast Cancer | p111_p3-92 | p.E224K | Private mutation |
| IVL | Breast Cancer | p111_p3-92 | p.L225H | Private mutation |
| IVL | Breast Cancer | p111_p3-92 | p.P226L | Private mutation |
| IVL | Colorectal Cancer | p034_MSU4 | Chr1:152882656:A>C | Private mutation |
| IVL | Colorectal Cancer | p040_case5 | Chr1:152883109:A>C | Private mutation |
| IVL | Esophageal Squamous Cell Carcinoma | p124_ESCC012 | p.E377Q | Branch mutation |
| IVL | Esophageal Squamous Cell Carcinoma | p139_EC0990 | p.Q79H | Private mutation |
| IVL | Esophageal Squamous Cell Carcinoma | p139_EC1117 | p.Q556X | Branch mutation |
| IVL | Gastric Carcinoma | p106_GC04 | p.L283L | Private mutation |
| IVL | Gastric Carcinoma | p106_GC07 | p.Q352R | Private mutation |
| IVL | Glioblastoma | p113_case08 | p.E338Q | Private mutation |
| IVL | Glioblastoma | p113_case14 | p.E338Q | Trunk mutation |
| IVL | Intrahepatic Cholangiocarcinoma | p080_ICC892 | p.Q392H | Private mutation |
| IVL | Intrahepatic Cholangiocarcinoma | p080_ICC892 | p.M280V | Private mutation |
| IVL | Lung Adenocarcinoma | p017_324s | Chr1:152882779:A>G | Trunk mutation |
| IVL | Lung Adenocarcinoma | p017_324s | Chr1:152883701:A>C | Trunk mutation |
| IVL | Lung Adenocarcinoma | p083_X324 | - | Trunk mutation |
| IVL | Lung Adenocarcinoma | p134_A014 | p.P104L | Branch mutation |
| IVL | Medulloblastoma | p072_MB5 | Chr1:152882157:G>T | Branch mutation |
| IVL | Melanoma | p043_F | p.P39L | Trunk mutation |
| IVL | Melanoma | p043_F | p.E577K | Trunk mutation |
| IVL | Melanoma | p043_F | p.E338K | Trunk mutation |
| IVL | Ovarian Cancer | p144_AOCS088 | p.E167E | Private mutation |
| IVL | Syndromic Neuroendocrine Carcinoma | p127_C2 | c.861N>G | Private mutation |